Explore the latest in radiation oncology, including recent advances in technologies and treatments and long-term radiotherapy complications.
This meta-analysis reviews 21 trials of stereotactic ablative radiotherapy administered to patients with oligometastatic cancer.
This cohort study evaluates whether machine learning models could identify patients with intermediate-risk head and neck squamous cell carcinoma who would benefit from chemoradiation.
This case series reports overall progression-free survival, widespread progression outcomes, and prognostic survival factors from a pooled data set of 1033 patients with oligometastasis treated with stereotactic body radiotherapy.
This nonrandomized controlled trial reports the oncological outcomes of the deintensification (from 50 Gy to 36 Gy) of a preoperative radiotherapy regimen for adults with myxoid liposarcoma.
This cohort study examined the association of adding ablative therapy to transarterial chemoembolization with overall survival and freedom from local progression among patients with hepatocellular carcinoma (HCC).
This narrative review discusses the use of postoperative radiotherapy in men with prostate cancer.
This cohort study examines the outcomes associated with initial transoral robotic surgery in older patients with human papillomavirus–associated oropharyngeal cancer.
This case series discusses 3 patients with Sézary syndrome who were treated with low-dose total skin electron beam therapy as part of a multimodality systemic regimen.
This cohort study examines the incidence of and mortality associated with second primary cancers that develop after diagnosis of retinoblastoma in Danish patients.
This systematic review and meta-analysis examines the reoperation rates reported in the literature before and after publication of the 2014 Society of Surgical Oncology–American Society for Radiation Oncology guideline for surgical management of invasive cancer.
This cohort study looks at outcomes and prognostic factors associated with overall survival and local control after hypofractionated stereotactic radiotherapy to the resection cavity of patients with brain metastases.
This Viewpoint discusses the advantages of having a dedicated metastatic disease radiation oncology program addressing the specific needs of patients with metastatic cancer.
This meta-analysis examines the association between human papillomavirus and survival in patients with oropharyngeal squamous cell carcinoma.
This randomized clinical trial assesses the efficacy and toxicity of radiotherapy plus icotinib compared with radiotherapy alone in older patients with unresectable esophageal squamous cell carcinoma (ESCC) in China.
This cohort study compares the risk of secondary sarcoma among patients treated with combinations of surgery, radiation, and chemotherapy with patients treated with surgery alone and with the general population.
A 62-year-old man presents with metastatic p16-positive squamous cell carcinoma and a primary cancer in the right tonsil. What is your diagnosis?
This cohort study uses National Cancer Database data from 2004 to 2014 to examine the association between overall survival and timing of radiotherapy relative to androgen deprivation therapy in patients with prostate cancer.
This quality improvement study assesses surface contamination with SARS-CoV-2 in the radiation oncology department of a large COVID-19 referral center and discusses implications for routine cleaning and disinfecting practices.
This case series study investigates the radiation doses delivered to organs at risk with modern involved-site radiation therapy among patients with early-stage favorable Hodgkin lymphoma treated with 20 Gy after 2 cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD).
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: